Key facts
- This page summarizes Paul A. Mahon's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2026, 17:09.
Paul A. Mahon - 15 Mar 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)
- Reporting relationship
- EVP & GENERAL COUNSEL
- Issuer ticker
- UTHR
- Reported as of
- 15 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Mar 2026, 17:09:43 UTC
- Prior SEC filing
- 05 Mar 2026
- Next SEC filing
- 19 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John S. Hess, Jr. under Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Paul A. Mahon filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 17 Mar 2026.
Change
- Previous filing in this sequence was filed on 05 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001231589
Primary reporting owner
MAHON PAUL A
- Relationship
- EVP & GENERAL COUNSEL
- Address
- C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
- Signature
- /s/ John S. Hess, Jr. under Power of Attorney
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
UTHR
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +8,895
- Change %
- +24%
- Price
- Shares after
- 45,739
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
UTHR
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,796
- Change %
- +17%
- Price
- Shares after
- 53,535
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
UTHR
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -4,457
- Change %
- -8.3%
- Price
- $536.12*
- Shares after
- 49,078
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
UTHR
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -3,906
- Change %
- -8%
- Price
- $536.12*
- Shares after
- 45,172
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
UTHR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -8,895
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,895
- Exercise price
- Footnotes
- F1, F3
UTHR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -7,796
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,796
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Footnote F2
Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
Footnote F3
Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.